[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100614238":3},{"organization":4,"armGroups":7,"interventions":24,"overallOfficials":33,"centralContacts":37,"locations":43,"responsibleParty":347,"collaborators":30,"id":349,"slug":350,"hasResults":351,"nctId":352,"briefTitle":353,"officialTitle":354,"acronym":30,"eligibilityCriteria":355,"healthyVolunteers":351,"sex":356,"minAge":357,"maxAge":358,"enrollmentInfo":359,"targetDuration":30,"studyType":362,"phases":363,"briefSummary":365,"conditions":366,"keywords":368,"overallStatus":46,"whyStopped":30,"lastUpdateSubmitDate":369,"lastUpdatePostDateStruct":370,"startDateStruct":373,"completionDateStruct":375,"leadSponsor":377,"locationsCount":378},{"fullName":5,"class":6},"AbbVie","INDUSTRY",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Icalcaprant Dose A","EXPERIMENTAL","Participants will receive oral Icalcaprant dose A once daily for 6 weeks and attend a follow up visit 30 days following end of treatment.",[13],"Drug: Icalcaprant",{"label":15,"type":10,"description":16,"interventionNames":17},"Icalcaprant Dose B","Participants will receive oral Icalcaprant dose B once daily for 6 weeks and attend a follow up visit 30 days following end of treatment.",[13],{"label":19,"type":20,"description":21,"interventionNames":22},"Placebo for Icalcaprant","PLACEBO_COMPARATOR","Participants will receive oral placebo once daily for 6 weeks and attend a follow up visit 30 days following end of treatment.",[23],"Drug: Placebo for Icalcaprant",[25,31],{"type":26,"name":27,"description":28,"armGroupLabels":29,"otherNames":30},"DRUG","Icalcaprant","Oral Capsules",[9,15],null,{"type":26,"name":19,"description":28,"armGroupLabels":32,"otherNames":30},[19],[34],{"name":35,"affiliation":5,"role":36},"ABBVIE INC.","STUDY_DIRECTOR",[38],{"name":39,"role":40,"phone":41,"phoneExt":30,"email":42},"ABBVIE CALL CENTER","CONTACT","844-663-3742","abbvieclinicaltrials@abbvie.com",[44,58,68,78,83,93,102,111,120,129,138,147,157,166,175,184,193,203,212,222,231,241,250,255,265,274,284,294,304,310,319,328,338],{"facility":45,"status":46,"city":47,"state":48,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":30},"Harmonex \u002FID# 277517","RECRUITING","Dothan","Alabama","36303","United States","US",{"type":53,"coordinates":54},"Point",[55,56],-85.39049,31.22323,{"lat":56,"lon":55},{"facility":59,"status":46,"city":60,"state":61,"zip":62,"country":50,"countryCode":51,"cosmosGeoPoint":63,"geoPoint":67,"contacts":30},"Ima Clinical Research Phoenix (Alea) \u002FID# 277516","Phoenix","Arizona","85012",{"type":53,"coordinates":64},[65,66],-112.07404,33.44838,{"lat":66,"lon":65},{"facility":69,"status":46,"city":70,"state":71,"zip":72,"country":50,"countryCode":51,"cosmosGeoPoint":73,"geoPoint":77,"contacts":30},"Preferred Research Partners \u002FID# 279206","Little Rock","Arkansas","72211",{"type":53,"coordinates":74},[75,76],-92.28959,34.74648,{"lat":76,"lon":75},{"facility":79,"status":46,"city":70,"state":71,"zip":72,"country":50,"countryCode":51,"cosmosGeoPoint":80,"geoPoint":82,"contacts":30},"Woodland International Research Group \u002FID# 277605",{"type":53,"coordinates":81},[75,76],{"lat":76,"lon":75},{"facility":84,"status":46,"city":85,"state":86,"zip":87,"country":50,"countryCode":51,"cosmosGeoPoint":88,"geoPoint":92,"contacts":30},"Advanced Research Center \u002FID# 277537","Anaheim","California","92805",{"type":53,"coordinates":89},[90,91],-117.9145,33.83529,{"lat":91,"lon":90},{"facility":94,"status":46,"city":95,"state":86,"zip":96,"country":50,"countryCode":51,"cosmosGeoPoint":97,"geoPoint":101,"contacts":30},"Sun Valley Research Center \u002FID# 277513","Imperial","92251",{"type":53,"coordinates":98},[99,100],-115.56944,32.84755,{"lat":100,"lon":99},{"facility":103,"status":46,"city":104,"state":86,"zip":105,"country":50,"countryCode":51,"cosmosGeoPoint":106,"geoPoint":110,"contacts":30},"Synergy San Diego \u002FID# 277553","Lemon Grove","91945",{"type":53,"coordinates":107},[108,109],-117.03142,32.74255,{"lat":109,"lon":108},{"facility":112,"status":46,"city":113,"state":86,"zip":114,"country":50,"countryCode":51,"cosmosGeoPoint":115,"geoPoint":119,"contacts":30},"Accellacare - Long Beach \u002FID# 279181","Long Beach","90807",{"type":53,"coordinates":116},[117,118],-118.18923,33.76696,{"lat":118,"lon":117},{"facility":121,"status":46,"city":122,"state":86,"zip":123,"country":50,"countryCode":51,"cosmosGeoPoint":124,"geoPoint":128,"contacts":30},"CenExel CNR \u002FID# 277533","Sherman Oaks","91403",{"type":53,"coordinates":125},[126,127],-118.44925,34.15112,{"lat":127,"lon":126},{"facility":130,"status":46,"city":131,"state":86,"zip":132,"country":50,"countryCode":51,"cosmosGeoPoint":133,"geoPoint":137,"contacts":30},"Inland Psychiatric Medical Group \u002FID# 279275","Temecula","92591",{"type":53,"coordinates":134},[135,136],-117.14836,33.49364,{"lat":136,"lon":135},{"facility":139,"status":46,"city":140,"state":86,"zip":141,"country":50,"countryCode":51,"cosmosGeoPoint":142,"geoPoint":146,"contacts":30},"Sunwise Clinical Research \u002FID# 277555","Walnut Creek","94596",{"type":53,"coordinates":143},[144,145],-122.06496,37.90631,{"lat":145,"lon":144},{"facility":148,"status":46,"city":149,"state":150,"zip":151,"country":50,"countryCode":51,"cosmosGeoPoint":152,"geoPoint":156,"contacts":30},"CenExel Hollywood FL \u002FID# 278200","Hollywood","Florida","33024",{"type":53,"coordinates":153},[154,155],-80.14949,26.0112,{"lat":155,"lon":154},{"facility":158,"status":46,"city":159,"state":150,"zip":160,"country":50,"countryCode":51,"cosmosGeoPoint":161,"geoPoint":165,"contacts":30},"Cns Healthcare - Jacksonville \u002FID# 277658","Jacksonville","32256",{"type":53,"coordinates":162},[163,164],-81.65565,30.33218,{"lat":164,"lon":163},{"facility":167,"status":46,"city":168,"state":150,"zip":169,"country":50,"countryCode":51,"cosmosGeoPoint":170,"geoPoint":174,"contacts":30},"GMI Florida - Central Miami Medical Institute \u002FID# 278218","Miami","33125",{"type":53,"coordinates":171},[172,173],-80.19366,25.77427,{"lat":173,"lon":172},{"facility":176,"status":46,"city":177,"state":150,"zip":178,"country":50,"countryCode":51,"cosmosGeoPoint":179,"geoPoint":183,"contacts":30},"Clinical Neuroscience Solutions - Orlando - East South Street \u002FID# 277558","Orlando","32801",{"type":53,"coordinates":180},[181,182],-81.37924,28.53834,{"lat":182,"lon":181},{"facility":185,"status":46,"city":186,"state":150,"zip":187,"country":50,"countryCode":51,"cosmosGeoPoint":188,"geoPoint":192,"contacts":30},"EquiPath Health & Research Tampa Bay, LLC \u002FID# 279128","Riverview","33578",{"type":53,"coordinates":189},[190,191],-82.32648,27.86614,{"lat":191,"lon":190},{"facility":194,"status":46,"city":195,"state":196,"zip":197,"country":50,"countryCode":51,"cosmosGeoPoint":198,"geoPoint":202,"contacts":30},"Trialmed \u002FID# 277601","Atlanta","Georgia","30328",{"type":53,"coordinates":199},[200,201],-84.38798,33.749,{"lat":201,"lon":200},{"facility":204,"status":46,"city":205,"state":196,"zip":206,"country":50,"countryCode":51,"cosmosGeoPoint":207,"geoPoint":211,"contacts":30},"Evergreen Clinical Trials - Norcross \u002FID# 279421","Norcross","30092",{"type":53,"coordinates":208},[209,210],-84.21353,33.94121,{"lat":210,"lon":209},{"facility":213,"status":46,"city":214,"state":215,"zip":216,"country":50,"countryCode":51,"cosmosGeoPoint":217,"geoPoint":221,"contacts":30},"Flourish Research - Great Lakes Clinical Trials \u002FID# 278201","Chicago","Illinois","60640",{"type":53,"coordinates":218},[219,220],-87.65005,41.85003,{"lat":220,"lon":219},{"facility":223,"status":46,"city":224,"state":215,"zip":225,"country":50,"countryCode":51,"cosmosGeoPoint":226,"geoPoint":230,"contacts":30},"Amr Conventions Research \u002FID# 277547","Warrenville","60555",{"type":53,"coordinates":227},[228,229],-88.1734,41.81781,{"lat":229,"lon":228},{"facility":232,"status":46,"city":233,"state":234,"zip":235,"country":50,"countryCode":51,"cosmosGeoPoint":236,"geoPoint":240,"contacts":30},"Redbird Research \u002FID# 277485","Las Vegas","Nevada","89119",{"type":53,"coordinates":237},[238,239],-115.13722,36.17497,{"lat":239,"lon":238},{"facility":242,"status":46,"city":243,"state":243,"zip":244,"country":50,"countryCode":51,"cosmosGeoPoint":245,"geoPoint":249,"contacts":30},"Ima Clinical Research - Manhattan \u002FID# 278212","New York","10036",{"type":53,"coordinates":246},[247,248],-74.00597,40.71427,{"lat":248,"lon":247},{"facility":251,"status":46,"city":243,"state":243,"zip":244,"country":50,"countryCode":51,"cosmosGeoPoint":252,"geoPoint":254,"contacts":30},"Manhattan Behavioral Medicine \u002FID# 277910",{"type":53,"coordinates":253},[247,248],{"lat":248,"lon":247},{"facility":256,"status":46,"city":257,"state":258,"zip":259,"country":50,"countryCode":51,"cosmosGeoPoint":260,"geoPoint":264,"contacts":30},"Quest Therapeutics of Avon \u002FID# 277550","Avon Lake","Ohio","44012-1004",{"type":53,"coordinates":261},[262,263],-82.0282,41.50532,{"lat":263,"lon":262},{"facility":266,"status":46,"city":267,"state":258,"zip":268,"country":50,"countryCode":51,"cosmosGeoPoint":269,"geoPoint":273,"contacts":30},"OSU Psychiatry Department \u002FID# 277529","Columbus","43210-1250",{"type":53,"coordinates":270},[271,272],-82.99879,39.96118,{"lat":272,"lon":271},{"facility":275,"status":46,"city":276,"state":277,"zip":278,"country":50,"countryCode":51,"cosmosGeoPoint":279,"geoPoint":283,"contacts":30},"Sooner Clinical Research \u002FID# 277659","Oklahoma City","Oklahoma","73116",{"type":53,"coordinates":280},[281,282],-97.51643,35.46756,{"lat":282,"lon":281},{"facility":285,"status":46,"city":286,"state":287,"zip":288,"country":50,"countryCode":51,"cosmosGeoPoint":289,"geoPoint":293,"contacts":30},"Clinical Neuroscience Solutions \u002FID# 278192","Memphis","Tennessee","38119",{"type":53,"coordinates":290},[291,292],-90.04898,35.14953,{"lat":292,"lon":291},{"facility":295,"status":46,"city":296,"state":297,"zip":298,"country":50,"countryCode":51,"cosmosGeoPoint":299,"geoPoint":303,"contacts":30},"Austin Clinical Trial Partners \u002FID# 279321","Austin","Texas","78737",{"type":53,"coordinates":300},[301,302],-97.74306,30.26715,{"lat":302,"lon":301},{"facility":305,"status":46,"city":296,"state":297,"zip":306,"country":50,"countryCode":51,"cosmosGeoPoint":307,"geoPoint":309,"contacts":30},"Community Clinical Research - Cross Park Drive \u002FID# 277935","78754",{"type":53,"coordinates":308},[301,302],{"lat":302,"lon":301},{"facility":311,"status":46,"city":312,"state":297,"zip":313,"country":50,"countryCode":51,"cosmosGeoPoint":314,"geoPoint":318,"contacts":30},"Houston Clinical Trials - Bellaire \u002FID# 277551","Bellaire","77401",{"type":53,"coordinates":315},[316,317],-95.45883,29.70579,{"lat":317,"lon":316},{"facility":320,"status":46,"city":321,"state":297,"zip":322,"country":50,"countryCode":51,"cosmosGeoPoint":323,"geoPoint":327,"contacts":30},"Pillar Clinical Research - Richardson \u002FID# 276764","Richardson","75080",{"type":53,"coordinates":324},[325,326],-96.72972,32.94818,{"lat":326,"lon":325},{"facility":329,"status":46,"city":330,"state":331,"zip":332,"country":50,"countryCode":51,"cosmosGeoPoint":333,"geoPoint":337,"contacts":30},"Northwest Clinical Research Center \u002FID# 277484","Bellevue","Washington","98007",{"type":53,"coordinates":334},[335,336],-122.20068,47.61038,{"lat":336,"lon":335},{"facility":339,"status":46,"city":340,"state":331,"zip":341,"country":50,"countryCode":51,"cosmosGeoPoint":342,"geoPoint":346,"contacts":30},"Core Clinical Research \u002FID# 277518","Everett","98201",{"type":53,"coordinates":343},[344,345],-122.20208,47.97898,{"lat":345,"lon":344},{"type":348,"investigatorFullName":30,"investigatorTitle":30,"investigatorAffiliation":30,"oldNameTitle":30,"oldOrganization":30},"SPONSOR","100614238","phase-2-a-study-to-assess-change-in-disease-activity-and-adverse-events-of-oral-icalcaprant-in-adult-participants-with-major-depressive-disorder-100614238",false,"NCT07276997","A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder","A Phase 2, Multicenter, 6-Week, Double Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Icalcaprant in Subjects With Major Depressive Disorder","Inclusion Criteria:\n\n* Participants with a diagnosis of major depressive disorder (MDD) according to the Diagnostic and Statistical Manual of Mental Disorders, fifth edition, text revision (DSM-5-TR) without psychotic features, confirmed by the Mini International Neuropsychiatric Interview (MINI) 7.0.\n* Body Mass Index (BMI) is ≥ 18.0 to ≤ 35.0 kg\u002Fm\\^2\n* Currently experiencing an major depressive episode (MDE) beginning at least 4 weeks prior to consent and not exceeding 6 months prior to Screening\n* Normal physical examination findings, clinical laboratory test results, vital signs, and 12-lead ECG results at Visit 1 or abnormal results that are judged not clinically significant by the investigator and documented as such in the eCRF.\n\nExclusion Criteria:\n\n* Has failed (no more than 25% response on Antidepressant Treatment History Questionnaire (ATRQ)) 3 or more antidepressant treatments during the current depressive episode despite an adequate dose (per ATRQ) and duration (at least 6 weeks).\n* History of an allergic reaction or significant sensitivity to constituents of the study drug (and its excipients) and\u002For other products in the same class.","ALL","18 Years","65 Years",{"count":360,"type":361},195,"ESTIMATED","INTERVENTIONAL",[364],"PHASE2","Major depressive disorder (MDD; depression) is a mood disorder that causes a continued feeling of sadness and loss of interest. It is a common and serious illness that can cause both emotional and physical symptoms such as feelings of sadness, irritability, not being able to focus on activities, tiredness, changes in eating habits, and aches and pains. This study will assess the changes in disease activity and adverse events of oral Icalcaprant in adult participants with major depressive disorder who are currently experiencing a major depressive episode (MDE).\n\nIcalcaprant is an investigational drug being developed for the treatment of depressive episodes in adult participants with major depressive disorder. Participants are placed in 1 of 3 groups, called treatment arms. There is a 1 in 3 chance that a participant will be assigned to placebo treatment. Around 195 adult participant with major depressive disorder will be enrolled in approximately 35 sites in North America.\n\nParticipants will receive oral capsules of Icalcaprant or matching placebo once daily for 6 weeks, with a 30-day safety follow-up.\n\nThere may be a higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.",[367],"Major Depressive Disorder",[367,27],"2026-06-11",{"date":371,"type":372},"2026-06-15","ACTUAL",{"date":374,"type":372},"2025-12-18",{"date":376,"type":361},"2027-09",{"name":5,"class":6},33]